191 related articles for article (PubMed ID: 32013770)
1. Zinc metal carboxylates as potential anti-Alzheimer's candidate:
Zafar R; Zubair M; Ali S; Shahid K; Waseem W; Naureen H; Haider A; Jan MS; Ullah F; Sirajuddin M; Sadiq A
J Biomol Struct Dyn; 2021 Feb; 39(3):1044-1054. PubMed ID: 32013770
[TBL] [Abstract][Full Text] [Related]
2. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
Zafar R; Naureen H; Zubair M; Shahid K; Saeed Jan M; Akhtar S; Ahmad H; Waseem W; Haider A; Ali S; Tariq M; Sadiq A
Drug Des Devel Ther; 2021; 15():2679-2694. PubMed ID: 34188447
[TBL] [Abstract][Full Text] [Related]
3. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
[TBL] [Abstract][Full Text] [Related]
4. Anticholinesterase and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer's and other neurological disorders.
Kamal Z; Ullah F; Ayaz M; Sadiq A; Ahmad S; Zeb A; Hussain A; Imran M
Biol Res; 2015 Apr; 48(1):21. PubMed ID: 25889712
[TBL] [Abstract][Full Text] [Related]
5. Isolation, identification, and quantification of Pentylcurcumene from Geophila repens: A new class of cholinesterase inhibitor for Alzheimer's disease.
Dash UC; Kanhar S; Dixit A; Dandapat J; Sahoo AK
Bioorg Chem; 2019 Jul; 88():102947. PubMed ID: 31028989
[TBL] [Abstract][Full Text] [Related]
6. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
[TBL] [Abstract][Full Text] [Related]
7. New 4-N-phenylaminoquinoline derivatives as antioxidant, metal chelating and cholinesterase inhibitors for Alzheimer's disease.
Cai R; Wang LN; Fan JJ; Geng SQ; Liu YM
Bioorg Chem; 2019 Dec; 93():103328. PubMed ID: 31600664
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, molecular docking studies, and biological evaluation of novel alkyl bis(4-amino-5-cyanopyrimidine) derivatives.
Boualia I; Derabli C; Boulcina R; Bensouici C; Yildirim M; Birinci Yildirim A; Mokrani EH; Debache A
Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900027. PubMed ID: 31448454
[TBL] [Abstract][Full Text] [Related]
9. Combining Experimental and Computational Methods to Produce Conjugates of Anticholinesterase and Antioxidant Pharmacophores with Linker Chemistries Affecting Biological Activities Related to Treatment of Alzheimer's Disease.
Makhaeva GF; Kovaleva NV; Rudakova EV; Boltneva NP; Lushchekina SV; Astakhova TY; Timokhina EN; Serkov IV; Proshin AN; Soldatova YV; Poletaeva DA; Faingold II; Mumyatova VA; Terentiev AA; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257233
[TBL] [Abstract][Full Text] [Related]
10. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Structure-Activity Relationships of Thiazole Analogs as Anticholinesterase Agents for Alzheimer's Disease.
Sağlık BN; Osmaniye D; Acar Çevik U; Levent S; Kaya Çavuşoğlu B; Özkay Y; Kaplancıklı ZA
Molecules; 2020 Sep; 25(18):. PubMed ID: 32962239
[TBL] [Abstract][Full Text] [Related]
12. Phytochemical profiling and in vitro screening for anticholinesterase, antioxidant, antiglucosidase and neuroprotective effect of three traditional medicinal plants for Alzheimer's Disease and Diabetes Mellitus dual therapy.
Penumala M; Zinka RB; Shaik JB; Mallepalli SKR; Vadde R; Amooru DG
BMC Complement Altern Med; 2018 Mar; 18(1):77. PubMed ID: 29499679
[TBL] [Abstract][Full Text] [Related]
13. New multitarget directed benzimidazole-2-thiol-based heterocycles as prospective anti-radical and anti-Alzheimer's agents.
Latif A; Bibi S; Ali S; Ammara A; Ahmad M; Khan A; Al-Harrasi A; Ullah F; Ali M
Drug Dev Res; 2021 Apr; 82(2):207-216. PubMed ID: 32897587
[TBL] [Abstract][Full Text] [Related]
14. Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: a preliminary anti- Alzheimer's study.
Ayaz M; Junaid M; Ullah F; Sadiq A; Khan MA; Ahmad W; Shah MR; Imran M; Ahmad S
Lipids Health Dis; 2015 Nov; 14():141. PubMed ID: 26530857
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of Benzimidazole-Based Analogs as Anti Alzheimer's Disease Compounds and Their Molecular Docking Studies.
Adalat B; Rahim F; Taha M; Alshamrani FJ; Anouar EH; Uddin N; Shah SAA; Ali Z; Zakaria ZA
Molecules; 2020 Oct; 25(20):. PubMed ID: 33092223
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant and anticholinesterase investigations of Rumex hastatus D. Don: potential effectiveness in oxidative stress and neurological disorders.
Ahmad S; Ullah F; Ayaz M; Sadiq A; Imran M
Biol Res; 2015 Mar; 48(1):20. PubMed ID: 25857346
[TBL] [Abstract][Full Text] [Related]
17. Aqueous extract of Securidaca longipendunculata Oliv. and Olax subscropioidea inhibits key enzymes (acetylcholinesterase and butyrylcholinesterase) linked with Alzheimer's disease in vitro.
Saliu JA; Olabiyi AA
Pharm Biol; 2017 Dec; 55(1):252-257. PubMed ID: 27927065
[TBL] [Abstract][Full Text] [Related]
18. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
[TBL] [Abstract][Full Text] [Related]
19. SAR based in-vitro anticholinesterase and molecular docking studies of nitrogenous progesterone derivatives.
Amin MJ; Miana GA; Rashid U; Rahman KM; Khan HU; Sadiq A
Steroids; 2020 Jun; 158():108599. PubMed ID: 32126219
[TBL] [Abstract][Full Text] [Related]
20. Screening and identification of secondary metabolites in the bark of
Khare N; Maheshwari SK; Jha AK
J Biomol Struct Dyn; 2021 Oct; 39(16):5988-5998. PubMed ID: 32720564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
